06.25.24 -- Managing Change In Vaccine Production With All Stakeholders

As more and more sponsors partner with CDMOs to leverage their expertise and capabilities, utilizing the right framework to manage a partner is crucial for the relationship to function optimally.

Achieving high-quality drug product requires a combination of meticulous quality control measures, personnel expertise, and judicious application of technology — benefiting patients and the industry.

Explore how a CMO with innovative practices and a successful approach to tech transfer and manufacturing processes can help meet project timelines and mitigate risk on the path to market.

The right manufacturing partnership could help a viral vector gene therapy sponsor's program to flourish. A CDMO’s project management, facilities, and expert staff can help accelerate patient access.

Finding a CDMO partner capable of guiding emerging biotechs throughout their product’s life cycle and accelerating time to market is crucial for maximizing the success of your novel therapeutic.

Review the pros and cons of soluble and insoluble processes, experiences with isolating, solubilizing, and properly re-folding, and strategies and innovation to improve insoluble processes.

Examine the challenges CGT innovators face and how adhering to GMP requirements from an early stage helps ensure successful downstream applications from clinical development to commercial phase.

By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.